Department NVS, Division of Nursing, Karolinska Institutet, Stockholm, Sweden.
Acta Oncol. 2011 Jan;50(1):112-20. doi: 10.3109/0284186X.2010.528790. Epub 2010 Nov 22.
cervical cancer screening (CCS) using Pap-smears has been carried out for decades and is still an essential tool for secondary cancer prevention. Focus has traditionally been on what hinders women's attendance, instead of researching this issue from a positive standpoint, i.e. what factors encourage women to take a Pap-smear? In this article, we therefore explore issues that 30-year-old women have addressed as encouraging CCS attendance, with particular focus on aspects susceptible to intervention.
through the population-based cervical cancer screening (PCCSP) registry in Stockholm, Sweden, a stratified random sampling technique was used to recruit women from the same birth cohort with varied CCS histories and results. Nine face-to-face focus groups discussions (FGDs) and 30 internet-based FGDs were conducted with a total of 138 women aged 30. Qualitative analysis was inspired by interpretative description, to generate clinically relevant and useful data.
in general, these women expressed positive views about the PCCSP as an existing service, regardless of screening history. They described a wide range of factors encompassing the entire screening trajectory from invitation through follow-up which could motivate young women to CCS participation, including social marketing. Many of the suggestions related to individualization of the PCCSP, as well as a need to understand the relationship between human papilloma virus (HPV) and cervical cancer.
[corrected these results are discussed in terms of the inherent tension between population-based public health initiatives and individually-oriented health care provision. Many suggestions given are already incorporated into the existing Stockholm-Gotland screening program, although this information may not reach women who need it. New research should test whether systematic information on HPV may provide a missing link in motivating young women to attend CCS, and which of their suggestions can serve to increase CCS participation.
巴氏涂片宫颈癌筛查(Pap 筛查)已经开展了几十年,仍是二级癌症预防的重要手段。传统上关注的是阻碍女性参加筛查的因素,而不是从积极的角度研究这个问题,即哪些因素鼓励女性进行巴氏涂片检查?在本文中,我们因此探讨了 30 岁女性认为有助于参加巴氏涂片检查的因素,特别关注易于干预的方面。
通过瑞典斯德哥尔摩基于人群的宫颈癌筛查(PCCSP)登记处,采用分层随机抽样技术,从具有不同巴氏涂片检查史和结果的同一生育队列中招募女性。共对 138 名 30 岁女性进行了 9 次面对面焦点小组讨论(FGD)和 30 次基于互联网的 FGD。定性分析受解释性描述的启发,以产生具有临床相关性和有用性的数据。
总的来说,这些女性对 PCCSP 作为现有服务表示了积极的看法,无论其筛查史如何。她们描述了一系列广泛的因素,涵盖了从邀请到随访的整个筛查过程,这些因素可能会激励年轻女性参与巴氏涂片检查,包括社会营销。许多建议与 PCCSP 的个体化有关,以及了解人乳头瘤病毒(HPV)与宫颈癌之间关系的必要性。
这些结果是根据基于人群的公共卫生倡议和以个人为导向的医疗保健提供之间的固有紧张关系进行讨论的。已经有许多建议被纳入现有的斯德哥尔摩-哥塔兰筛查计划中,尽管这些信息可能无法传达给需要的女性。新的研究应该测试关于 HPV 的系统信息是否可以为激励年轻女性参加巴氏涂片检查提供缺失的环节,以及她们的哪些建议可以增加巴氏涂片检查的参与度。